Drugs

targeting G-Protein Coupled Receptor G-Protein Coupled Receptors (GPCRs) are a large family of cell surface receptors that are involved in many important bodily functions and pathways. Drugs that target GPCRs are used to treat a variety of illnesses, such as heart disease, depression, obesity, and cancer. GPCR drugs are designed to bind to the receptor and activate or inhibit its activity, leading to therapeutic effects. GPCRs are also being studied as potential therapeutic targets for a range of other disorders, including diabetes and inflammation. GPCR-targeted drugs are an increasingly important part of modern medicine, with the potential to improve the quality of life for countless patients around the world.

← Journal of Drug Resistant Pathogen Research

Related Articles

6 article(s) found
Current Status of Nonsteroidal Anti-Inflammatory Drugs in Colorectal Cancer Prevention
Full-text HTML Download PDF Download XML
Why New Drugs, Treatments, and Medical Devices Still Needs to be Tested Clinically Before Making it Available in the Market?
Full-text HTML Download PDF Download XML
Successful Cascade of Care and Cure HCV in 5382 Drugs Users: How Increase HCV Treatment by Outreach Care, Since Screening to Treatment
Full-text HTML Download PDF Download XML
Assessment of Self Medication Practice and Drugs Storage Among South Sudanese Community in Addis Ababa, Ethiopia
Full-text HTML Download PDF Download XML
Spirometric profile of people living with HIV on antiretroviral drugs in Abidjan
Full-text HTML Download PDF Download XML
Measuring Quality Change in the Market for Anti-Ulcer Drugs
Full-text HTML Download PDF Download XML